Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis. (Q48255358)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

title

Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Jean-François Fournier

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

author name string

Nicolas Atrux-Tallau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Franck Bihl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Aline Bondu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Claire Bouix-Peter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Isabelle Carlavan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Olivier Christin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Marie-Josée Cuadrado

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Claire Defoin-Platel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Sophie Deret

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Denis Duvert

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Christophe Feret

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Mathieu Forissier

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

David Froude

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Fériel Hacini-Rachinel

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Craig Steven Harris

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Catherine Hervouet

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Hélène Huguet

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Guillaume Lafitte

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Anne-Pascale Luzy

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Branislav Musicki

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Danielle Orfila

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Benjamin Ozello

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Coralie Pascau

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Jonathan Pascau

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Véronique Parnet

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Guillaume Peluchon

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Romain Pierre

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

David Piwnica

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Catherine Raffin

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Patricia Rossio

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Delphine Spiesse

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Nathalie Taquet

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Etienne Thoreau

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Rodolphe Vatinel

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Emmanuel Vial

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Laurent François Hennequin

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

publication date

6 February 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

321-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

RORγ antagonists and inverse agonists: a patent review

9 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Recent progress on nuclear receptor RORγ modulators

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

REV-ERB and ROR nuclear receptors as drug targets.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

IL-17/Th17 pathway is activated in acne lesions

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Discovery and process development of a novel TACE inhibitor for the topical treatment of psoriasis.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

RORγt inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

3-alkoxy-pyrrolo[1,2-b]pyrazolines as selective androgen receptor modulators with ideal physicochemical properties for transdermal administration

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Lipophilicity in drug discovery

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Regioselective synthesis of 2H-indazoles through Ga/Al- and Al-mediated direct alkylation reactions of indazoles

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Novel preparation of chiral α-amino acids using the Mitsunobu-Tsunoda reaction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Copper-mediated N-cyclopropylation of azoles, amides, and sulfonamides by cyclopropylboronic acid.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Discovery of a series of 8-(2,3-dihydro-1,4-benzoxazin-4-ylmethyl)-2-morpholino-4-oxo-chromene-6-carboxamides as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Tosylhydrazones: new uses for classic reagents in palladium-catalyzed cross-coupling and metal-free reactions

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Prediction of drug solubility by the general solubility equation (GSE).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patients

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

CCR6 is required for IL-23-induced psoriasis-like inflammation in mice

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700758

7 January 2021

Identifiers

DOI

10.1002/CMDC.201700758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29327456%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference